bpc 157 clinical trial nct Today, May 6, 2026, Mirum Pharmaceuticals (@mirumpharma) announced to its investors that it has licensed the drug zilurgisertib, an ALK2 kinase inhibitor, currently being developed by Incyte (@incyte) for FOP (PROGRESS Phase Glutathione:Glutathione farm Top Packaged Mineral Water
SKU: 44276977923
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8























![Olivestam, Carl [red.] | PANDEMIER : Dåtid och nutid för framtid KOMPILATORISK FRAMSTÄLLNING](https://cdn.shopify.com/s/files/1/0651/8856/1163/files/45057211_8d5f08c7-9c76-4c6e-9fe9-8ba2af88a65b.jpg?v=1740653017)
